Rich McAvoy named Chief Business Officer at Avid. Read the Release
Rich McAvoy named Chief Business Officer at Avid. Read the Release
You’re Invited: Opening Ceremony for Avid’s New Early-Phase Center of Excellence, Costa Mesa Avid Bioservices is pleased to invite you to the grand opening ceremony for our new early-phase biologics development and manufacturing center located in Costa Mesa, California. This special event marks the official opening and the expansion of Avid’s capabilities to support early-phase biologics programs with flexible single-use capacity, platform-standardized processes, and an integrated development model built for speed, scientific clarity, and scalability. We would be delighted to have you join us as we celebrate this important milestone for Avid and the biopharma innovators we serve. Event Details What to Expect The new facility was designed with emerging and early-phase biopharma programs in mind offering right-sized manufacturing, integrated development services, and a seamless path toward scalable bulk drug substance production. We look forward to sharing this new facility with you and discussing how it can support your future programs. 
Early-Phase Center of Excellence Grand Opening
February 24 @ 1:00 pm - 6:00 pm
Date: February 24, 2026
Time: 1:00 PM – 5:00 PM
Location: 3030 Airway Ave, Costa Mesa, 92626, CA
• Welcome reception with lunch & networking
• Remarks from Avid’s executive and technical leadership
• Official ribbon-cutting ceremony
• Guided tours of the new early-phase center
• Opportunities to connect with Avid’s scientific, operational, and business teams
Seasoned business and finance leader brings growth mindset to support Avid’s next phase expansion and client execution TUSTIN, Calif. — [January 15, 2026] — Avid Bioservices, a leading contract development […]
Read moreThe newly created role marks a major step in CEO Kenneth Bilenberg’s vision to scale Avid for its next chapter of growth. TUSTIN, Calif., November 10, 2025 – Avid […]
Read moreTustin, CA, USA – September 15, 2025 – Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), today announced the appointment of Kenneth Bilenberg as its new […]
Read moreSOUTH SAN FRANCISCO, California – August 05, 2025 – Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical […]
Read moreDownload PDF Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO […]
Read moreDownload PDFAvid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger TUSTIN, Calif., February 5, 2025 — Avid […]
Read more